首页> 美国卫生研究院文献>other >Two-Stage Residual Inclusion Estimation: Addressing Endogeneity in Health Econometric Modeling
【2h】

Two-Stage Residual Inclusion Estimation: Addressing Endogeneity in Health Econometric Modeling

机译:两阶段残差包含估计:解决健康计量经济学建模中的内生性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The paper focuses on two estimation methods that have been widely used to address endogeneity in empirical research in health economics and health services research B two-stage predictor substitution (2SPS) and two-stage residual inclusion (2SRI). 2SPS is the rote extension (to nonlinear models) of the popular linear two-stage least squares estimator. The 2SRI estimator is similar except that in the second stage regression, the endogenous variables are not replaced by first-stage predictors. Instead, first-stage residuals are included as additional regressors. In a generic parametric framework, we show that 2SRI is consistent and 2SPS is not. Results from a simulation study and an illustrative example also recommend against 2SPS and favor 2SRI. Our findings are important given that there are many prominent examples of the application of inconsistent 2SPS in the recent literature. This study can be used as a guide by future researchers in health economics who are confronted with endogeneity in their empirical work.
机译:本文着重讨论了两种估计方法,这些方法已广泛用于解决卫生经济学和卫生服务研究的经验研究中的内生性B两阶段预测变量替换(2SPS)和两阶段残差包含(2SRI)。 2SPS是流行的线性两阶段最小二乘估计器的强壮扩展(到非线性模型)。 2SRI估计量类似,除了在第二阶段回归中,内生变量不会被第一阶段预测变量代替。取而代之的是,将第一阶段的残差包括在内,作为其他回归变量。在通用参数框架中,我们表明2SRI是一致的,而2SPS不是一致的。模拟研究的结果和一个示例性实例也建议反对2SPS,并赞成2SRI。鉴于最近文献中有许多突出的例子说明了不一致2SPS的应用,因此我们的发现很重要。未来的健康经济学研究人员可以将这项研究用作指导,他们的经验工作面临内生性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号